The FY20 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Ovarian Cancer Research Program to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.
The FY 2020 Defense Appropriations Bill has not been signed into law—and although FY20 funds have not been appropriated for the Department of Defense Ovarian Cancer Research Program, the OCRP has published information to allow investigators time to plan and develop ideas for submission to the anticipated FY20 funding opportunities.
FY20 OCRP program announcements and general application instructions for the following award mechanism is posted on the Grants.gov website.
